Aesthetic Medical International Holdings Group Ltd (PAIYY) reported a modest revenue decline of 3.5% in the first half of 2025, with active customers down 6% year-over-year primarily due to strategic reductions in advertising and a shift toward emphasizing senior physician-led treatments. The firm introduced the 7S On-Site Management Method, improving service environment efficiency and patient experience, resulting in better adjusted EBITDA despite revenue softness. While competitive pressures and market sensitivity to consumer spending pose growth challenges, operational discipline and targeted marketing pivots underpin measured resilience as the company navigates evolving demand dynamics in China’s key urban markets.